SAGE - 3 Stocks That Are Giving Their Investors Coal in Their Stockings
No CEO should be evaluated on their company's stock performance in a single year . Strategies often take several years to play out. When a company's fortunes depend on drug development, the timeline can be even longer. That's why no investor should take it too hard that Galapagos NV (NASDAQ: GLPG) , Sage Therapeutics (NASDAQ: SAGE) , and bluebird bio (NASDAQ: BLUE) have had a rough year.
The stocks could have wildly different outcomes in 2021, although recent developments make it seem like they are as likely to stage a comeback as they are to throw in the towel. During the holiday season, parents often tell misbehaving kids that Santa won't bring them what they want for Christmas. With share prices down dramatically from all-time highs, let's find out why shareholders of these three biotechs are getting coal in their stockings this year.
Image source: Getty Images.
For further details see:
3 Stocks That Are Giving Their Investors Coal in Their Stockings